anmeldenSXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.19 | Roche Hold | Deutsche Bank AG | |
| 11.01.19 | Novartis Hold | Deutsche Bank AG | |
| 08.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.01.19 | Roche overweight | JP Morgan Chase & Co. | |
| 02.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 14.12.18 | Novartis Equal-Weight | Morgan Stanley | |
| 14.12.18 | Roche overweight | Morgan Stanley | |
| 14.12.18 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.12.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
| 14.12.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 13.12.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 11.12.18 | Novartis buy | Jefferies & Company Inc. | |
| 11.12.18 | Roche buy | Jefferies & Company Inc. | |
| 10.12.18 | Roche Neutral | UBS AG | |
| 10.12.18 | Roche Hold | Deutsche Bank AG | |
| 10.12.18 | Novartis Hold | Deutsche Bank AG | |
| 10.12.18 | Novartis buy | Kepler Cheuvreux | |
| 10.12.18 | Novartis Underweight | Barclays Capital | |
| 08.12.18 | Novartis Underweight | Barclays Capital | |
| 05.12.18 | Roche overweight | JP Morgan Chase & Co. | |
| 03.12.18 | Roche buy | Baader Bank | |
| 03.12.18 | Roche overweight | JP Morgan Chase & Co. | |
| 28.11.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.11.18 | Novartis Hold | HSBC | |
| 21.11.18 | Novartis Neutral | UBS AG | |
| 19.11.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 06.11.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.11.18 | Roche overweight | JP Morgan Chase & Co. | |
| 01.11.18 | Roche overweight | JP Morgan Chase & Co. | |
| 01.11.18 | Roche buy | Baader Bank | |
| 25.10.18 | Novartis Hold | HSBC | |
| 23.10.18 | Roche Neutral | UBS AG | |
| 22.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 22.10.18 | Roche overweight | JP Morgan Chase & Co. | |
| 22.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 22.10.18 | Roche Hold | Deutsche Bank AG | |
| 22.10.18 | Novartis Hold | Deutsche Bank AG | |
| 19.10.18 | Novartis Hold | Baader Bank | |
| 19.10.18 | Novartis Neutral | Credit Suisse Group | |
| 18.10.18 | Novartis buy | CFRA |
